Form D · Private Equity Fund
RMGP Bio-Pharma Investment Fund, L.P.
Herzliya, L3 · CIK 0001756063
Offering snapshot reported Oct 22, 2018 · SEC filing
- Reported sold
- $2M Offering amount: $80M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2018 | Initial | $2,000,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324062
Source: Form D, filed Oct 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Assaf Keret | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
11 Ha'manofim Street Ackerstein Towers (Building B, 10th Floo
Herzliya, L3, 46140
Herzliya, L3, 46140